Pancreatic neuroendocrine tumors (PanNENs) are rare sporadic cancers or develop as part
of hereditary syndromes. PanNENs can be both functioning and non-functioning based on …

Pancreatic neuroendocrine neoplasms (PanNENs) are rare, highly heterogeneous tumours.
There have been significant recent advances in our knowledge of genomic events …

Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with
neuroendocrine differentiation that show characteristic clinical, histomorphologic, and …

Pancreatic neuroendocrine neoplasms (PanNENs) contain two primary subtypes with
distinct molecular features and associated clinical outcomes: well-differentiated …

Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with
neuroendocrine differentiation that show peculiar clinical and histomorphological features …

Pancreatic neuroendocrine neoplasms (pNENs) are rare cancers with broad challenges for
their management. The main clinical obstacles are the high rate of patients diagnosed at …

Pancreatic neuroendocrine tumours (PanNETs) are considered a relatively unusual
oncologic entity. Due to its relative good prognosis, surgery remains the goal standard …

Pancreatic neuroendocrine neoplasms (panNENs) are the second most common epithelial
tumors of the pancreas. Despite improvements in prognostic grading and staging systems, it …

Pancreatic neuroendocrine tumours (PanNETs) are rare diseases and a good example of
how research is not only feasible, but also of crucial importance in the scenario of rare …

The first classification of the pancreatic neuroendocrine neoplasms (PanNENs) that
characterized the individual tumor by criteria with prognostic significance appeared in 1995 …